Goodwill and Intangible Assets

6 Months Ended

Jun. 30, 2017

Goodwill And Intangible Assets Disclosure [Abstract]

6.	Goodwill and Intangible Assets

(Table only in thousands)	Six months ended June 30, 2017				Year ended December 31, 2016
Goodwill / Indefinite Life Tradenames	Goodwill		Tradenames		Goodwill			Tradenames
Beginning balance	$	170,153	$	22,042	$	220,163		$	26,337
Acquisitions and related adjustments		—		—		4,205			—
Impairment		—		—		(53,762	)		(4,161	)
Foreign currency translation		694		226		(453	)		(134	)
	$	170,847	$	22,268	$	170,153		$	22,042

(Table only in thousands)	As of June 30, 2017						As of December 31, 2016
Intangible assets – finite life	Cost			Accum. Amort.			Cost			Accum. Amort.
Technology	$	15,867		$	7,472		$	15,867		$	6,360
Customer lists		77,497			30,524			77,497			26,041
Noncompetition agreements		1,118			588			1,118			478
Tradename		1,390			371			1,390			301
Foreign currency adjustments		(1,900	)		(432	)		(2,964	)		(1,000	)
	$	93,972		$	38,523		$	92,908		$	32,180

Activity for the six months ended June 30, 2017 and 2016 is as follows:

(Table only in thousands)	2017			2016
Intangible assets – finite life, net at beginning of period	$	60,728		$	74,957
Amortization expense		(5,772	)		(7,645	)
Foreign currency adjustments		493			76
Intangible assets – finite life, net at end of period	$	55,449		$	67,388

Amortization expense of finite life intangible assets was $2.9 million and $3.7 million for the three-month periods ended June 30, 2017 and 2016, respectively, and $5.8 million and $7.6 million for the six-month periods ended June 30, 2017 and 2016, respectively.

The Company did not identify any triggering events during the three-month and six-month periods ended June 30, 2017 that would require an interim impairment assessment of goodwill or indefinite life intangible assets. There was no impairment of goodwill or indefinite life intangible assets during the three-month and six-month periods ended June 30, 2017.

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details